De novo CD5+ diffuse large B-cell lymphomas

A heterogeneous group containing an unusual form of splenic lymphoma

Steven H. Kroft, Michael S. Howard, Louis Picker, M. Qasim Ansari, Deborah B. Aquino, Robert W. McKenna

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

We reviewed our institutional experience with de novo CD5+, large B-cell lymphomas to determine whether they represent a distinct entity and are related to CD5+ small B-cell disorders. We identified 13 cases with multiparameter flow cytometry over a period of 58 months (5% of large B-cell lymphomas) in 7 females and 6 males. Three groups were identified. Group 1 (2 cases) had diffuse splenic red pulp involvement with a distinctive cordal pattern of infiltration, no other clinical evidence of mass disease, microscopic disseminated disease on further workup, and an identical immunoglobulin-negative immunophenotype. Group 2 cases (7 cases) were clinically and morphologically heterogeneous and had an immunophenotype resembling mantle cell lymphoma (FMC7-positive, CD23-). Group 3 (4 cases) had miscellaneous immunophenotypes, including one closely resembling chronic lymphocytic leukemia. Cyclin D1 was positive in only 1 of 10 evaluable cases (group 2). We conclude that CD5+ diffuse large B-cell lymphomas are heterogeneous; most cases do not seem to be related to chronic lymphocytic leukemia or mantle cell lymphoma. However, we identified a subgroup of primary splenic CD5+ large B-cell lymphoma with diffuse red pulp involvement and believe this may represent a distinct clinicopathologic entity.

Original languageEnglish (US)
Pages (from-to)523-533
Number of pages11
JournalAmerican Journal of Clinical Pathology
Volume114
Issue number4
DOIs
StatePublished - Oct 2000
Externally publishedYes

Fingerprint

Mantle-Cell Lymphoma
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Lymphoma
Cyclin D1
Immunoglobulins
Flow Cytometry
B-Lymphocytes

Keywords

  • CD5
  • Cyclin D1
  • Large cell lymphoma
  • Mantle cell lymphoma
  • Splenic lymphoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

De novo CD5+ diffuse large B-cell lymphomas : A heterogeneous group containing an unusual form of splenic lymphoma. / Kroft, Steven H.; Howard, Michael S.; Picker, Louis; Ansari, M. Qasim; Aquino, Deborah B.; McKenna, Robert W.

In: American Journal of Clinical Pathology, Vol. 114, No. 4, 10.2000, p. 523-533.

Research output: Contribution to journalArticle

Kroft, Steven H. ; Howard, Michael S. ; Picker, Louis ; Ansari, M. Qasim ; Aquino, Deborah B. ; McKenna, Robert W. / De novo CD5+ diffuse large B-cell lymphomas : A heterogeneous group containing an unusual form of splenic lymphoma. In: American Journal of Clinical Pathology. 2000 ; Vol. 114, No. 4. pp. 523-533.
@article{ce93f89363924658827fb82b178a555e,
title = "De novo CD5+ diffuse large B-cell lymphomas: A heterogeneous group containing an unusual form of splenic lymphoma",
abstract = "We reviewed our institutional experience with de novo CD5+, large B-cell lymphomas to determine whether they represent a distinct entity and are related to CD5+ small B-cell disorders. We identified 13 cases with multiparameter flow cytometry over a period of 58 months (5{\%} of large B-cell lymphomas) in 7 females and 6 males. Three groups were identified. Group 1 (2 cases) had diffuse splenic red pulp involvement with a distinctive cordal pattern of infiltration, no other clinical evidence of mass disease, microscopic disseminated disease on further workup, and an identical immunoglobulin-negative immunophenotype. Group 2 cases (7 cases) were clinically and morphologically heterogeneous and had an immunophenotype resembling mantle cell lymphoma (FMC7-positive, CD23-). Group 3 (4 cases) had miscellaneous immunophenotypes, including one closely resembling chronic lymphocytic leukemia. Cyclin D1 was positive in only 1 of 10 evaluable cases (group 2). We conclude that CD5+ diffuse large B-cell lymphomas are heterogeneous; most cases do not seem to be related to chronic lymphocytic leukemia or mantle cell lymphoma. However, we identified a subgroup of primary splenic CD5+ large B-cell lymphoma with diffuse red pulp involvement and believe this may represent a distinct clinicopathologic entity.",
keywords = "CD5, Cyclin D1, Large cell lymphoma, Mantle cell lymphoma, Splenic lymphoma",
author = "Kroft, {Steven H.} and Howard, {Michael S.} and Louis Picker and Ansari, {M. Qasim} and Aquino, {Deborah B.} and McKenna, {Robert W.}",
year = "2000",
month = "10",
doi = "10.1309/RM1Q-1T0B-WKQB-AF5A",
language = "English (US)",
volume = "114",
pages = "523--533",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "4",

}

TY - JOUR

T1 - De novo CD5+ diffuse large B-cell lymphomas

T2 - A heterogeneous group containing an unusual form of splenic lymphoma

AU - Kroft, Steven H.

AU - Howard, Michael S.

AU - Picker, Louis

AU - Ansari, M. Qasim

AU - Aquino, Deborah B.

AU - McKenna, Robert W.

PY - 2000/10

Y1 - 2000/10

N2 - We reviewed our institutional experience with de novo CD5+, large B-cell lymphomas to determine whether they represent a distinct entity and are related to CD5+ small B-cell disorders. We identified 13 cases with multiparameter flow cytometry over a period of 58 months (5% of large B-cell lymphomas) in 7 females and 6 males. Three groups were identified. Group 1 (2 cases) had diffuse splenic red pulp involvement with a distinctive cordal pattern of infiltration, no other clinical evidence of mass disease, microscopic disseminated disease on further workup, and an identical immunoglobulin-negative immunophenotype. Group 2 cases (7 cases) were clinically and morphologically heterogeneous and had an immunophenotype resembling mantle cell lymphoma (FMC7-positive, CD23-). Group 3 (4 cases) had miscellaneous immunophenotypes, including one closely resembling chronic lymphocytic leukemia. Cyclin D1 was positive in only 1 of 10 evaluable cases (group 2). We conclude that CD5+ diffuse large B-cell lymphomas are heterogeneous; most cases do not seem to be related to chronic lymphocytic leukemia or mantle cell lymphoma. However, we identified a subgroup of primary splenic CD5+ large B-cell lymphoma with diffuse red pulp involvement and believe this may represent a distinct clinicopathologic entity.

AB - We reviewed our institutional experience with de novo CD5+, large B-cell lymphomas to determine whether they represent a distinct entity and are related to CD5+ small B-cell disorders. We identified 13 cases with multiparameter flow cytometry over a period of 58 months (5% of large B-cell lymphomas) in 7 females and 6 males. Three groups were identified. Group 1 (2 cases) had diffuse splenic red pulp involvement with a distinctive cordal pattern of infiltration, no other clinical evidence of mass disease, microscopic disseminated disease on further workup, and an identical immunoglobulin-negative immunophenotype. Group 2 cases (7 cases) were clinically and morphologically heterogeneous and had an immunophenotype resembling mantle cell lymphoma (FMC7-positive, CD23-). Group 3 (4 cases) had miscellaneous immunophenotypes, including one closely resembling chronic lymphocytic leukemia. Cyclin D1 was positive in only 1 of 10 evaluable cases (group 2). We conclude that CD5+ diffuse large B-cell lymphomas are heterogeneous; most cases do not seem to be related to chronic lymphocytic leukemia or mantle cell lymphoma. However, we identified a subgroup of primary splenic CD5+ large B-cell lymphoma with diffuse red pulp involvement and believe this may represent a distinct clinicopathologic entity.

KW - CD5

KW - Cyclin D1

KW - Large cell lymphoma

KW - Mantle cell lymphoma

KW - Splenic lymphoma

UR - http://www.scopus.com/inward/record.url?scp=0034425259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034425259&partnerID=8YFLogxK

U2 - 10.1309/RM1Q-1T0B-WKQB-AF5A

DO - 10.1309/RM1Q-1T0B-WKQB-AF5A

M3 - Article

VL - 114

SP - 523

EP - 533

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 4

ER -